Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 12, 2018, the company operated approximately 180 locations in 32 states, including ambulatory surgery centers, surgical hospitals, a diagnostic laboratory, multi-specialty physician practices, and urgent care facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900
Debt
Debt-to-Equity Ratio1.63
Current Ratio1.72
Quick Ratio1.55
Price-To-Earnings
Trailing P/E Ratio-18.45
Forward P/E Ratio-28.18
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.34 billion
Price / Sales0.57
Cash Flow$0.3156 per share
Price / Cash49.12
Book Value$27.41 per share
Price / Book0.57
Profitability
EPS (Most Recent Fiscal Year)($0.84)
Net Income$-52,980,000.00
Net Margins-5.13%
Return on Equity-1.90%
Return on Assets-0.50%
Miscellaneous
Employees10,600
Outstanding Shares48,910,000
Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions
What is Surgery Partners' stock symbol?
Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."
How will Surgery Partners' stock buyback program work?
Surgery Partners announced that its board has approved a share buyback plan on Saturday, December 16th 2017, which allows the company to buyback $50,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback plans are typically an indication that the company's leadership believes its shares are undervalued.
How were Surgery Partners' earnings last quarter?
Surgery Partners Inc (NASDAQ:SGRY) released its quarterly earnings results on Wednesday, May, 9th. The company reported ($0.26) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.05. The business earned $417.37 million during the quarter, compared to the consensus estimate of $410.79 million. Surgery Partners had a negative return on equity of 1.90% and a negative net margin of 5.13%. The business's quarterly revenue was up 45.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.06) EPS. View Surgery Partners' Earnings History.
When is Surgery Partners' next earnings date?
What price target have analysts set for SGRY?
8 brokers have issued 1 year target prices for Surgery Partners' shares. Their predictions range from $15.00 to $19.00. On average, they expect Surgery Partners' share price to reach $17.6667 in the next year. View Analyst Ratings for Surgery Partners.
Who are some of Surgery Partners' key competitors?
Who are Surgery Partners' key executives?
Surgery Partners' management team includes the folowing people:
- Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 47)
- Mr. Dennis Dean, Sr. VP & Corp. Controller (Age 46)
- Mr. Clifford G. Adlerz, Consultant & Director (Age 64)
- Ms. Teresa F. Sparks, Consultant (Age 49)
- Mr. Wayne Scott DeVeydt, CEO & Director (Age 48)
Has Surgery Partners been receiving favorable news coverage?
Headlines about SGRY stock have been trending somewhat negative this week, Accern reports. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Surgery Partners earned a daily sentiment score of -0.06 on Accern's scale. They also gave news articles about the company an impact score of 46.77 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
Who are Surgery Partners' major shareholders?
Surgery Partners' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.64%), Elk Creek Partners LLC (1.21%), JPMorgan Chase & Co. (1.11%), Dimensional Fund Advisors LP (1.11%), Point72 Asset Management L.P. (0.73%) and Northern Trust Corp (0.47%). Company insiders that own Surgery Partners stock include HIG Surgery Centers, Llc and Jennifer Baldock. View Institutional Ownership Trends for Surgery Partners.
Which institutional investors are selling Surgery Partners stock?
SGRY stock was sold by a variety of institutional investors in the last quarter, including Highland Capital Management LP, JPMorgan Chase & Co., Sei Investments Co., Elk Creek Partners LLC, BlackRock Inc. and Northern Trust Corp. View Insider Buying and Selling for Surgery Partners.
Which institutional investors are buying Surgery Partners stock?
SGRY stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BNP Paribas Arbitrage SA, Millennium Management LLC, Dimensional Fund Advisors LP, GSA Capital Partners LLP, Schwab Charles Investment Management Inc. and MetLife Investment Advisors LLC. View Insider Buying and Selling for Surgery Partners.
How do I buy shares of Surgery Partners?
Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Surgery Partners' stock price today?
One share of SGRY stock can currently be purchased for approximately $15.50.
How big of a company is Surgery Partners?
Surgery Partners has a market capitalization of $772.82 million and generates $1.34 billion in revenue each year. The company earns $-52,980,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Surgery Partners employs 10,600 workers across the globe.
How can I contact Surgery Partners?
Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]
MarketBeat Community Rating for Surgery Partners (SGRY)
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
